PBH - Prestige Consumer Healthcare Inc

NYSE * Health Care * Pharmaceuticals

$57.57

+$0.91 (+1.61%)

About Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

PBH Key Statistics

Market Cap

$2.72B

P/E Ratio

14.95

P/B Ratio

1.46

EPS

$3.79

Revenue Growth

-0.0%

Profit Margin

0.2%

Employees

600

How PBH Compares to Peers

PBH has the lowest P/E ratio in Pharmaceuticals, suggesting it may be the most undervalued
PBH has the highest profit margins in Pharmaceuticals
PBH is the smallest among peers, which may offer higher growth potential

P/E Rank

#1

of 2

Margin Rank

#1

of 2

Growth Rank

#2

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
PBH14.9-0%-
AMZN34.60%vs AMZN

Prestige Consumer Healthcare Inc Company Information

Headquarters
New York; U.S.A
Website
www.prestigebrands.com
Sector
Health Care
Industry
Pharmaceuticals
Data Updated:
Ready to invest in PBH?

Commission-free trading available. Affiliate links.

PBH Lician Score

10% confidence
5.0/10
Neutral

PBH has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates PBHacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

PBH Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

35810Value5.0Growth3.0Quality5.0Momentum5.0Safety5.04.6/10
5.0

Value

3.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for PBH